Sign in

CIK 0001551152

  • Large accelerated filer

AbbVie Inc.

Sign in to watch
Ticker
ABBV
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320375147
Phone
+1 847-932-7900
Business address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,925,738
in 1 filing

Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stewart Jeffrey Ryan −$11.9M EVP, CHIEF COMMERCIAL OFFICER sold 33% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-27 Thakkar Roopal EVP, R&D and CSO Shares withheld for taxes −8,037 $232.08 $1.9M 52,376
2026-02-18 Thakkar Roopal EVP, R&D and CSO Grant or award +6,015 48,291
2026-02-18 Thakkar Roopal EVP, R&D and CSO Grant or award +2,138 50,429
2026-02-18 Thakkar Roopal EVP, R&D and CSO Grant or award +3,346 53,775
2026-02-18 Thakkar Roopal EVP, R&D and CSO Grant or award +6,638 60,413
2026-02-18 Thakkar Roopal EVP, R&D and CSO Grant or award · Option (Right to buy) +21,937 21,937
2025-02-28 Thakkar Roopal EVP, R&D and CSO Shares withheld for taxes −4,678 $205.02 $959K 42,276
2025-02-13 Thakkar Roopal EVP, R&D and CSO Grant or award +3,595 39,994
2025-02-13 Thakkar Roopal EVP, R&D and CSO Grant or award +1,474 41,468
2025-02-13 Thakkar Roopal EVP, R&D and CSO Grant or award +2,138 43,606
2025-02-13 Thakkar Roopal EVP, R&D and CSO Grant or award +3,348 46,954
2025-02-13 Thakkar Roopal EVP, R&D and CSO Grant or award · Option (Right to buy) +25,000 25,000
2024-02-28 Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS Shares withheld for taxes −4,914 $178.99 $880K 23,259
2024-02-15 Thakkar Roopal EVP, R&D and CSO Grant or award +5,900 36,125
2024-02-15 Thakkar Roopal EVP, R&D and CSO Grant or award +1,572 37,697
2024-02-15 Thakkar Roopal EVP, R&D and CSO Grant or award +1,476 39,173
2024-02-15 Thakkar Roopal EVP, R&D and CSO Grant or award +2,140 41,313
2024-02-15 Thakkar Roopal EVP, R&D and CSO Grant or award · Option (Right to buy) +13,868 13,868
2024-02-15 Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS Grant or award +8,022 18,399
2024-02-15 Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS Grant or award +2,138 20,537

Page 1 of 2 · 23 trades